The absence of Smyd2 in lymphomas arising with CD19-CRE was confirmed at the mRNA level (Figure 10B): it is noteworthy here that lymphomas are generally monoclonal, explaining the full loss of Smyd2, while mixed pre-tumoral populations still showed residual expression (Figure 9A). This evidence concerns the gene CD19 and lymphoma.